No molecular studies to date have analyzed the effect of anti-TNF treatment in EO-IBD, and future studies to investigate the pharmacokinetics of anti-TNF treatment in EO-IBD are warranted. The gene discussed is TNF; the disease is inflammatory bowel disease.